Biomarkers (journal)
Biomarkers is a peer-reviewed scientific journal published by Taylor & Francis. It focuses on the study and application of biomarkers in various fields of medicine, biology, and environmental science. The journal's primary scope encompasses the identification, validation, and application of biomarkers for disease diagnosis, prognosis, monitoring treatment response, and risk assessment.
The journal publishes original research articles, reviews, short communications, and letters to the editor. Key areas covered include, but are not limited to:
- Disease Biomarkers: Identification and validation of biomarkers for a wide range of diseases, including cancer, cardiovascular disease, neurological disorders, infectious diseases, and autoimmune diseases.
- Pharmacodynamic and Pharmacogenomic Biomarkers: Biomarkers used to assess drug response and predict individual variations in drug efficacy and toxicity.
- Toxicological Biomarkers: Biomarkers used to assess exposure to environmental toxins and their effects on human health.
- Biomarker Technology: Development and application of new technologies for biomarker discovery and analysis, including genomics, proteomics, metabolomics, and imaging techniques.
- Clinical Applications of Biomarkers: Translation of biomarker research into clinical practice, including the development of diagnostic tests and personalized treatment strategies.
- Methodological Aspects: Studies focused on improving the methodology for biomarker studies, including study design, sample collection, data analysis, and statistical methods.
The target audience for Biomarkers includes researchers, clinicians, and other professionals working in fields related to biomarker discovery, development, and application. The journal aims to provide a forum for the dissemination of high-quality research and to promote the translation of biomarker findings into improved healthcare and environmental monitoring.
The journal is indexed in major databases such as PubMed/MEDLINE, Scopus, and Web of Science.